Advanced search
Publication Cover
Substance Use & Misuse Volume 48, 2013 - Issue 7
Submit an article Journal homepage
115
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

CYP2A6 Genotype and Smoking Behavior in Current Smokers Screened for Lung Cancer

Mindi A. StynDepartment of Health and Community Systems, University of Pittsburgh School of Nursing, Pittsburgh, Pennsylvania, USA;Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USACorrespondence[email protected]
,
Tomoko NukuiCenter for Clinical Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
,
Marjorie RomkesCenter for Clinical Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA;University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA
,
Kenneth A. PerkinsDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
,
Stephanie R. LandTobacco Control Research Branch, Behavioral Research Program, National Cancer Institute, Washington, District of Columbia, USA
&
Joel L. WeissfeldDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA;University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA
Pages 490-494 | Published online: 25 Mar 2013

REFERENCES

  • Aarskog, N. K., & Vedeler, C. A. (2000). Real-time quantitative polymerase chain reaction: a new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Human Genetics, 107(5), 494–498.
  • Benowitz, N. L., Swan, G. E., Jacob, P., III, Lessov-Schlaggar, C. N., & Tyndale, R. F. (2006). CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clinical Pharmacology & Therapeutics, 80(5), 457–467.
  • Cox, L. S., Faseru, B., Mayo, M. S., Krebill, R., Snow, T. S., Bronars, C. A., (2011). Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data. Trials, 12, 22.
  • GeneWatch UK. (2004). Three reasons not to buy the NicoTest™ genetic test. Retrieved November 9, 2012, from http://www. genewatch.org/uploads/f03c6d66a9b354535738483c1c3d49e4/ Nicotest_brief_final.pdf
  • Gilles, P. N., Wu, D. J., Foster, C. B., Dillon, P. J., & Chanock, S. J. (1999). Single nucleotide polymorphic discrimination by an electronic dot blot assay on semiconductor microchips. Nature Biotechnology, 17(4), 365–370.
  • Lerman, C., Jepson, C., Wileyto, E. P., Patterson, F., Schnoll, R., Mroziewicz, M., (2010). Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clinical Pharmacology & Therapeutics, 87(5), 553–557.
  • Malarcher, A., Dube, S., Shaw, L., Babb, S., & Kaufmann, R. (2011). Quitting smoking among adults: United States, 2001–2010. Morbidity and Mortality Weekly Report, 60(44), 1513–1519.
  • Schaeffeler, E., Schwab, M., Eichelbaum, M., & Zanger, U. M. (2003). CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Human Mutation, 22(6), 476–485.
  • Strasser, A., Benowitz, N., Pinto, A., Tang, K., Hecht, S., Carmella, S., (2011). Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiology, Biomarkers & Prevention, 20(2), 234–238.
  • Styn, M. A., Nukui, T., Romkes, M., Perkins, K., Land, S. R., & Weissfeld, J. L. (2009). The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study. American Journal of Medical Genetics, 150B(2), 254–261.
  • Swan, G. E., Lessov-Schlaggar, C. N., Bergen, A. W., He, Y., Tyndale, R. F., & Benowitz, N. L. (2009). Genetic and environmental influences on the ratio of 3′hydroxycotinine to cotinine in plasma and urine. Pharmacogenetics and Genomics, 19(5), 388–398.
  • Wassenaar, C., Dong, Q., Wei, Q., Amos, C., Spitz, M., & Tyndale, R. (2011). Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. Journal of the National Cancer Institute, 103(17), 1342–1346.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.